ERIC STORCH to Antidepressive Agents
This is a "connection" page, showing publications ERIC STORCH has written about Antidepressive Agents.
Connection Strength
2.009
-
A meta-analysis of dropout rates from exposure with response prevention and pharmacological treatment for youth with obsessive compulsive disorder. Depress Anxiety. 2020 05; 37(5):407-417.
Score: 0.546
-
Randomized, placebo-controlled trial of cognitive-behavioral therapy alone or combined with sertraline in the treatment of pediatric obsessive-compulsive disorder. Behav Res Ther. 2013 Dec; 51(12):823-9.
Score: 0.357
-
The nature, assessment, and treatment of obsessive-compulsive disorder. Postgrad Med. 2012 Jan; 124(1):152-65.
Score: 0.316
-
Risk of adverse behavioral effects with pediatric use of antidepressants. Psychopharmacology (Berl). 2007 Mar; 191(1):87-96.
Score: 0.223
-
Pediatric Treatment-Resistant Obsessive Compulsive Disorder: Treatment Options and Challenges. Paediatr Drugs. 2024 Jul; 26(4):397-409.
Score: 0.187
-
Efficacy of D-cycloserine augmented brief intensive cognitive-behavioural therapy for paediatric obsessive-compulsive disorder: A randomised clinical trial. Depress Anxiety. 2022 06; 39(6):461-473.
Score: 0.159
-
D-Cycloserine Augmentation of Exposure-Based Cognitive Behavior Therapy for Anxiety, Obsessive-Compulsive, and Posttraumatic Stress Disorders: A Systematic Review and Meta-analysis of Individual Participant Data. JAMA Psychiatry. 2017 05 01; 74(5):501-510.
Score: 0.114
-
Aripiprazole augmentation of incomplete treatment response in an adolescent male with obsessive-compulsive disorder. Depress Anxiety. 2008; 25(2):172-4.
Score: 0.060
-
The relationship between subjective effects induced by a single dose of ketamine and treatment response in patients with major depressive disorder: A systematic review. J Affect Disord. 2020 03 01; 264:123-129.
Score: 0.034
-
Obsessive-compulsive disorder in Tourette syndrome. J Child Neurol. 2006 Aug; 21(8):704-14.
Score: 0.014